AarogyaAI aims to diagnose drug-resistant tuberculosis (DR-TB) using artificial intelligence in a few hours. We enable quick and accurate diagnosis of DR-TB so that the patient can be rightly prescribed effective drug combinations for treatment, instantly.
Our co-founders, Praapti and Avlokita, are motivated by their life experiences to develop a solution for the growing challenges of DR-TB. Praapti, grew up in a family of doctors and was motivated to address public health issues using her scientific training in infectious diseases. Avlokita, lost her grandmother to tuberculosis and wanted to be a part of the solution working towards eliminating this disease.
In India today, Tuberculosis affects 2.7 million people each year, and thousands of people die because of it. However, there is a disproportionate focus on solving micro problems in research which, do not translate into public application. Our aim is to bridge that gap.
We are greatly inspired by Dr. Soumya Swaminathan, Chief Scientist at WHO and a tuberculosis physician. Dr.Swaminathan took a keen interest in our objectives and, is our mentor on this journey.
In March 2020, AarogyaAI won the BIRAC TiE WInER Award. The award is given to Women in Entrepreneurial Research by the Biotechnology Industry Research Assistance Council (BIRAC). BIRAC was set up by Department of Biotechnology (DBT), Government of India with a vision to foster and enhance research and innovation capabilities of the Indian biotech industry. 
PhD-holder Praapti Jayasawal and Computational Biologist Avlokita Tiwari have built an Artificial Intelligence (AI) enabled SaaS (Software as a Service) that diagnoses drug-resistant tuberculosis (DR-TB) and enable effective treatment, instantly. This is unlike the existing drug-resistant tuberculosis diagnostics, which takes four to six weeks. 